Telomere shortening in patients with plasma cell disorders

Alejandra Cottliar1, Estela Pedrazzini, Claudia Corrado

  • 1Departamento de Genética, Instituto de Investigaciones Hematológicas Mariano R. Castex, Academia Nacional de Medicina, Buenos Aires, Argentina. acottliar@yahoo.com.ar

Abstract

Insights

Multiple myeloma patients exhibit significantly shortened telomere length (TL), correlating with disease progression and abnormal karyotypes. Telomere length is restored in remission, suggesting a link to clinical evolution.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Telomeres are crucial for chromosomal integrity, and their shortening is linked to genomic instability.
  • Understanding telomere dynamics in hematological malignancies like multiple myeloma (MM) is vital for prognosis.

Purpose of the Study:

  • To investigate telomere length (TL) in bone marrow (BM) cells of patients with multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS).
  • To explore the relationship between TL, disease status, and cytogenetic abnormalities in MM.

Main Methods:

  • Terminal restriction fragment (TRF) assay was used to evaluate TL in 31 MM patients (at diagnosis, relapse, remission) and 2 MGUS cases.
  • Cytogenetic, molecular cytogenetic analyses, and telomeric associations (TAs) on BM metaphases were performed.

Main Results:

  • MM patients showed significantly shorter mean TRF values compared to controls (5.20 vs. 8.5 kb).
  • Telomere shortening was pronounced at diagnosis and relapse, with restoration in remission, correlating with BM plasma cell infiltration and abnormal karyotypes.
  • Increased telomeric associations were observed in MM patients compared to MGUS and normal controls.

Conclusions:

  • Reduced TL in MM, particularly with high plasma cell infiltration and abnormal karyotypes, suggests a role in disease progression.
  • Telomere shortening appears to contribute to increased telomeric associations and chromosomal instability in MM.

Related Concept Videos

Replication in Eukaryotes02:31

Replication in Eukaryotes

Overview
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...